Your browser doesn't support javascript.
loading
DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC.
Wei, Jinhuan; Lu, Jun; Cao, Yun; Yao, Gaosheng; Huang, Yong; Zhao, Hongwei; Pan, Yihui; Feng, Zihao; Chen, Zhenhua; Chen, Wei; Luo, Junhang; Cao, Jiazheng.
Affiliation
  • Wei J; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Lu J; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Cao Y; Department of Pathology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Yao G; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Huang Y; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Zhao H; Department of Urology, Affiliated Yantai Yuhuangding Hospital, Qingdao University Medical College, Yantai, China.
  • Pan Y; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Feng Z; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Chen Z; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Chen W; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Luo J; Department of Urology, First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Cao J; Department of Urology, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yet-Sen University, Jiangmen, Guangdong, China.
Curr Cancer Drug Targets ; 21(10): 849-859, 2021.
Article de En | MEDLINE | ID: mdl-34382524
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Tumeurs du rein Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Curr Cancer Drug Targets Sujet du journal: ANTINEOPLASICOS / NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Tumeurs du rein Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Curr Cancer Drug Targets Sujet du journal: ANTINEOPLASICOS / NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas